Ghayad et al. [54] showed that the PI3K/PTEN/AKT pathway has been linked to promotion of survival in breast cancer cells, resistance to chemotherapy, resistance to endocrine therapy, and has been associated with poor prognosis. Here, PTEN is linked to breast carcinoma.